• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脑屏障:神经药物的一个障碍。

Blood-brain barrier: an impediment to neuropharmaceuticals.

作者信息

Henderson J T, Piquette-Miller M

机构信息

Leslie Dan Faculty of Pharmacy, University of Toronto, Ontario, Canada.

出版信息

Clin Pharmacol Ther. 2015 Apr;97(4):308-13. doi: 10.1002/cpt.77. Epub 2015 Feb 24.

DOI:10.1002/cpt.77
PMID:25670372
Abstract

The blood-brain barrier (BBB) serves as a highly selective barrier separating the central nervous system from the systemic circulation. Although contributing to neurological health, the BBB restricts the ability of drugs to reach their site of action and thus presents a major challenge to the treatment of neurological disorders. Advances in our understanding of the complexity of the BBB have fostered development of novel pharmacometric models and drug delivery strategies to better predict and improve therapeutic access.

摘要

血脑屏障(BBB)是一种高度选择性的屏障,将中枢神经系统与体循环分隔开来。尽管血脑屏障有助于神经健康,但它限制了药物到达其作用部位的能力,因此对神经系统疾病的治疗构成了重大挑战。我们对血脑屏障复杂性认识的进展推动了新型药代动力学模型和药物递送策略的发展,以更好地预测和改善治疗药物的可达性。

相似文献

1
Blood-brain barrier: an impediment to neuropharmaceuticals.血脑屏障:神经药物的一个障碍。
Clin Pharmacol Ther. 2015 Apr;97(4):308-13. doi: 10.1002/cpt.77. Epub 2015 Feb 24.
2
Translational aspects of blood-brain barrier transport and central nervous system effects of drugs: from discovery to patients.血脑屏障转运的转化研究及药物对中枢神经系统的影响:从发现到临床应用
Clin Pharmacol Ther. 2015 Apr;97(4):380-94. doi: 10.1002/cpt.76. Epub 2015 Feb 20.
3
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.向中枢神经系统输送治疗药物:问题与可能性
Pharmacol Ther. 2004 Oct;104(1):29-45. doi: 10.1016/j.pharmthera.2004.08.001.
4
New experimental models of the blood-brain barrier for CNS drug discovery.用于中枢神经系统药物发现的血脑屏障新实验模型。
Expert Opin Drug Discov. 2017 Jan;12(1):89-103. doi: 10.1080/17460441.2017.1253676. Epub 2016 Nov 7.
5
Modern methods for delivery of drugs across the blood-brain barrier.现代跨越血脑屏障递药方法。
Adv Drug Deliv Rev. 2012 May 15;64(7):640-65. doi: 10.1016/j.addr.2011.11.010. Epub 2011 Nov 28.
6
The blood-brain barrier: bottleneck in brain drug development.血脑屏障:脑药物研发的瓶颈
NeuroRx. 2005 Jan;2(1):3-14. doi: 10.1602/neurorx.2.1.3.
7
Nano-enabled delivery systems across the blood-brain barrier.纳米载体透过血脑屏障的递药系统。
Arch Pharm Res. 2014 Jan;37(1):24-30. doi: 10.1007/s12272-013-0272-6. Epub 2013 Oct 30.
8
Modulation of drug transporters at the blood-brain barrier.
Pharmacology. 2004 Apr;70(4):169-76. doi: 10.1159/000075545.
9
Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.应用体外模型预测人体血脑屏障药物渗透性的障碍:特别关注转运体和代谢酶。
Curr Drug Metab. 2013 Jan;14(1):120-36.
10
The concept of fraction of drug transported (ft ) with special emphasis on BBB efflux of CNS and antiretroviral drugs.药物转运分数(ft)的概念,特别强调中枢神经系统和抗逆转录病毒药物的血脑屏障外排。
Clin Pharmacol Ther. 2015 Apr;97(4):320-3. doi: 10.1002/cpt.72. Epub 2015 Feb 13.

引用本文的文献

1
Ultrasound-responsive nanoparticles for imaging and therapy of brain tumors.用于脑肿瘤成像与治疗的超声响应性纳米颗粒。
Mater Today Bio. 2025 Mar 17;32:101661. doi: 10.1016/j.mtbio.2025.101661. eCollection 2025 Jun.
2
Expanding horizons in theragnostics: from oncology to multidisciplinary applications.拓展诊疗一体化的视野:从肿瘤学到多学科应用
Radiol Med. 2025 Mar 5. doi: 10.1007/s11547-025-01971-7.
3
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis.
发现和临床前特征分析 BIIB129,一种共价、选择性、可穿透血脑屏障的 BTK 抑制剂,用于多发性硬化症的治疗。
J Med Chem. 2024 May 23;67(10):8122-8140. doi: 10.1021/acs.jmedchem.4c00220. Epub 2024 May 7.
4
Mechanistic Modeling of Intrathecal Chemotherapy Pharmacokinetics in the Human Central Nervous System.鞘内化疗药代动力学的人体中枢神经系统的机制建模。
Clin Cancer Res. 2024 Apr 1;30(7):1397-1408. doi: 10.1158/1078-0432.CCR-23-3062.
5
Rifampicin and protein concentrations in paired spinal versus ventricular cerebrospinal fluid samples of children with tuberculous meningitis.利福平与蛋白在结核性脑膜炎患儿配对的脊髓与脑室脑脊液样本中的浓度。
J Antimicrob Chemother. 2024 Feb 1;79(2):280-286. doi: 10.1093/jac/dkad371.
6
Spinal cord vascular degeneration impairs duloxetine penetration.脊髓血管变性会削弱度洛西汀的渗透。
Front Pain Res (Lausanne). 2023 May 26;4:1190440. doi: 10.3389/fpain.2023.1190440. eCollection 2023.
7
Multiscale modelling of claudin-based assemblies: A magnifying glass for novel structures of biological interfaces.基于紧密连接蛋白的组装体的多尺度建模:生物界面新结构的放大镜
Comput Struct Biotechnol J. 2022 Oct 28;20:5984-6010. doi: 10.1016/j.csbj.2022.10.038. eCollection 2022.
8
Mechanistic Modeling of Central Nervous System Pharmacokinetics and Target Engagement of HER2 Tyrosine Kinase Inhibitors to Inform Treatment of Breast Cancer Brain Metastases.中枢神经系统药代动力学和 HER2 酪氨酸激酶抑制剂的靶点结合的机制模型研究,为乳腺癌脑转移的治疗提供信息。
Clin Cancer Res. 2022 Aug 2;28(15):3329-3341. doi: 10.1158/1078-0432.CCR-22-0405.
9
Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery.CRISPR-Cas9系统在研究药物递送生物屏障中的应用。
Pharmaceutics. 2022 Apr 20;14(5):894. doi: 10.3390/pharmaceutics14050894.
10
The Bradykinin B2 Receptor Agonist (NG291) Causes Rapid Onset of Transient Blood-Brain Barrier Disruption Without Evidence of Early Brain Injury.缓激肽B2受体激动剂(NG291)可导致血脑屏障迅速发生短暂性破坏,且无早期脑损伤迹象。
Front Neurosci. 2021 Dec 15;15:791709. doi: 10.3389/fnins.2021.791709. eCollection 2021.